BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3121810)

  • 1. 99mTc-diphosphonate whole-body retention measurements using a conic-beam collimator and a scintillation detector.
    Vattimo A
    J Nucl Med Allied Sci; 1987; 31(3):291-4. PubMed ID: 3121810
    [No Abstract]   [Full Text] [Related]  

  • 2. [24-hour whole-body retention of 99mTc-methylene diphosphonate as an indicator of metabolic activity in osseous tissue in osteopathies].
    Kapitola J; Jahoda I; Kobos L; Vilimovská D
    Cas Lek Cesk; 1986 Jun; 125(26):815-6. PubMed ID: 3087622
    [No Abstract]   [Full Text] [Related]  

  • 3. 24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.
    Hyldstrup L
    Dan Med Bull; 1989 Sep; 36(4):349-58. PubMed ID: 2509145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
    Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
    Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
    Hyldstrup L; McNair P; Ring P; Henriksen O
    Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
    Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of age on the 24-hour retention of TC-99m methylene diphosphonate in rats].
    Kapitola J; Kobos L; Jahoda I
    Sb Lek; 1987 Apr; 89(4):102-7. PubMed ID: 3112927
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
    Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
    Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemibody uptake on bone scintigraphy in polyostotic fibrous dysplasia.
    Rudenko B; Klingelschmitt S; Aubry S; Bamba M; Boulahdour H
    Clin Nucl Med; 2003 Dec; 28(12):992-3. PubMed ID: 14663327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Soft tissue visualization with 99m Tc-HDP in a case of dermatomyositis].
    Ruiz Franco-Baux JV; García Hernández FJ; Correa García M; Castillo Palma MJ; Sánchez Román J; Rodríguez Rodríguez JR
    Rev Esp Med Nucl; 1999; 18(2):109. PubMed ID: 10352324
    [No Abstract]   [Full Text] [Related]  

  • 14. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Algodystrophy in adults with hypofixation during bone scintigraphy using technetium 99m-methylene diphosphonate].
    Sereni D; Khalifa P; Richard B; Doury P; Cremer GA
    Rev Rhum Mal Osteoartic; 1987 Nov; 54(11):767-9. PubMed ID: 3423721
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral symmetrical Ollier disease and Tc-99m MDP bone scintigraphy.
    Kaya H; Komek H; Cerci SS; Tuzcu SA
    Clin Nucl Med; 2004 Jul; 29(7):456. PubMed ID: 15192478
    [No Abstract]   [Full Text] [Related]  

  • 17. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
    Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
    Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy.
    Kida T; Narita S
    Eur J Nucl Med; 1987; 13(1):36-40. PubMed ID: 3109916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lutein cyst inadvertently detected on Tc-99m MDP whole-body bone scintigraphy.
    Kida T; Takahashi S
    Clin Nucl Med; 1998 Jan; 23(1):52-3. PubMed ID: 9442974
    [No Abstract]   [Full Text] [Related]  

  • 20. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
    Littlefield JL; Rudd TG
    J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.